1
|
Meisel JD, Miranda M, Skinner OS, Wiesenthal PP, Wellner SM, Jourdain AA, Ruvkun G, Mootha VK. Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism. Cell 2024; 187:659-675.e18. [PMID: 38215760 PMCID: PMC10919891 DOI: 10.1016/j.cell.2023.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 09/09/2023] [Accepted: 12/05/2023] [Indexed: 01/14/2024]
Abstract
The electron transport chain (ETC) of mitochondria, bacteria, and archaea couples electron flow to proton pumping and is adapted to diverse oxygen environments. Remarkably, in mice, neurological disease due to ETC complex I dysfunction is rescued by hypoxia through unknown mechanisms. Here, we show that hypoxia rescue and hyperoxia sensitivity of complex I deficiency are evolutionarily conserved to C. elegans and are specific to mutants that compromise the electron-conducting matrix arm. We show that hypoxia rescue does not involve the hypoxia-inducible factor pathway or attenuation of reactive oxygen species. To discover the mechanism, we use C. elegans genetic screens to identify suppressor mutations in the complex I accessory subunit NDUFA6/nuo-3 that phenocopy hypoxia rescue. We show that NDUFA6/nuo-3(G60D) or hypoxia directly restores complex I forward activity, with downstream rescue of ETC flux and, in some cases, complex I levels. Additional screens identify residues within the ubiquinone binding pocket as being required for the rescue by NDUFA6/nuo-3(G60D) or hypoxia. This reveals oxygen-sensitive coupling between an accessory subunit and the quinone binding pocket of complex I that can restore forward activity in the same manner as hypoxia.
Collapse
Affiliation(s)
- Joshua D Meisel
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Maria Miranda
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Owen S Skinner
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Presli P Wiesenthal
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA
| | - Sandra M Wellner
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Alexis A Jourdain
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Gary Ruvkun
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
| | - Vamsi K Mootha
- Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
| |
Collapse
|
2
|
Romero FJ, Diaz-Llopis M, Romero-Gomez MI, Miranda M, Romero-Wenz R, Sancho-Pelluz J, Romero B, Muriach M, Barcia JM. Small Extracellular Vesicles and Oxidative Pathophysiological Mechanisms in Retinal Degenerative Diseases. Int J Mol Sci 2024; 25:1618. [PMID: 38338894 PMCID: PMC10855665 DOI: 10.3390/ijms25031618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2024] [Revised: 01/20/2024] [Accepted: 01/26/2024] [Indexed: 02/12/2024] Open
Abstract
This review focuses on the role of small extracellular vesicles in the pathophysiological mechanisms of retinal degenerative diseases. Many of these mechanisms are related to or modulated by the oxidative burden of retinal cells. It has been recently demonstrated that cellular communication in the retina involves extracellular vesicles and that their rate of release and cargo features might be affected by the cellular environment, and in some instances, they might also be mediated by autophagy. The fate of these vesicles is diverse: they could end up in circulation being used as markers, or target neighbor cells modulating gene and protein expression, or eventually, in angiogenesis. Neovascularization in the retina promotes vision loss in diseases such as diabetic retinopathy and age-related macular degeneration. The importance of micro RNAs, either as small extracellular vesicles' cargo or free circulating, in the regulation of retinal angiogenesis is also discussed.
Collapse
Affiliation(s)
- Francisco J. Romero
- Hospital General de Requena, Conselleria de Sanitat, Generalitat Valenciana, 46340 Requena, Spain;
| | - Manuel Diaz-Llopis
- Facultad de Medicina y Odontología, Universitat de València, 46010 Valencia, Spain;
| | | | - Maria Miranda
- Facultad de Ciencias de la Salud, Universidad CEU-Cardenal Herrera, 46115 Alfara del Patriarca, Spain;
| | - Rebeca Romero-Wenz
- Hospital General de Requena, Conselleria de Sanitat, Generalitat Valenciana, 46340 Requena, Spain;
| | - Javier Sancho-Pelluz
- Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia, 46001 Valencia, Spain; (J.S.-P.); (B.R.); (J.M.B.)
| | - Belén Romero
- Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia, 46001 Valencia, Spain; (J.S.-P.); (B.R.); (J.M.B.)
- Unidad de Cuidados intensivos, Hospital de Manises, 46940 Manises, Spain
| | - Maria Muriach
- Facultad de Ciencias de la Salud, Universitat Jaume I, 12006 Castelló de la Plana, Spain;
| | - Jorge M. Barcia
- Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia, 46001 Valencia, Spain; (J.S.-P.); (B.R.); (J.M.B.)
| |
Collapse
|
3
|
Ahmadinia L, Rangrej SB, Miranda M, Shailer C, Ahmed W, Carvalho V, Rathore R. The Potential Role of NOD2/CARD15 Genotype as a Prognostic Indicator for Bone Marrow Transplantation Outcomes in Patients With Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: A Systematic Review. Cureus 2024; 16:e52329. [PMID: 38361685 PMCID: PMC10866692 DOI: 10.7759/cureus.52329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/29/2023] [Indexed: 02/17/2024] Open
Abstract
Hematopoietic stem-cell transplantation (HSCT) has emerged as a groundbreaking therapeutic option for acute myeloid leukemia (AML) and specific subtypes of acute lymphoblastic leukemia (ALL). The prognostic significance of the NOD2/CARD15 gene has been explored alongside various factors, encompassing diverse patient cohorts and gene variants. Siblings and unrelated donors used for stem cell transplantation exhibit significant associations between their genetic variations and graft-versus-host disease incidence. The transplantation of stem cells for leukemia patients involves numerous considerations, including patient survival, relapse rates, disease stage, donor and recipient ages, and compatibility. This study delved into research on the NOD2/CARD15 gene and its mutations to assess its suitability as a screening tool. A comprehensive literature search encompassing PubMed, ScienceDirect, and Google Scholar articles yielded 4,840 articles. After removing duplicates and applying inclusion and exclusion criteria, we narrowed the search results to 876 articles. Subsequent screening of abstracts and titles resulted in the selection of 230 relevant articles. Further exclusion of 198 articles unrelated to the research question led to the scrutinizing of 32 full-text articles, which were assessed against inclusion and exclusion criteria. Emphasis was placed on articles that specifically investigated the role of NOD2/CARD15 as a predictive factor for HSCT outcomes, ultimately resulting in the inclusion of 19 articles in this study. Single nucleotide polymorphisms (SNPs) such as NOD2 and CARD15 have demonstrated their potential as reliable genetic markers for predicting post-transplantation relapse and disease outcomes. Patients positive for these genetic markers have exhibited reduced overall survival and event-free survival and increased transplant-related mortality. Interventions with interferon-gamma and muramyl tripeptide phosphatidylethanolamine have been considered to mitigate the inflammatory effects of these SNPs, thus enhancing the influence of natural killer cells on abnormal cells and potentially extending patient survival. NOD2/CARD15 typing may aid in identifying patients at higher risk for relapse and improving their clinical outcomes after allogeneic stem cell transplant, particularly in ALL patients. However, no remarkable change was observed in AML patients. Additionally, this study underscores the pivotal roles of adaptive and innate immune responses and their interplay in stem cell transplant immunology.
Collapse
Affiliation(s)
- Leila Ahmadinia
- Basic Sciences, Saint James School of Medicine, Arnos Vale, VCT
| | - Shahid B Rangrej
- Anatomy/Research, Saint James School of Medicine, Arnos Vale, VCT
| | - Maria Miranda
- Basic Sciences, Saint James School of Medicine, Arnos Vale, VCT
| | | | - Waleed Ahmed
- Basic Sciences, Saint James School of Medicine, Arnos Vale, VCT
| | | | - Rajni Rathore
- Pharmacology and Therapeutics, Saint James School of Medicine, Arnos Vale, VCT
| |
Collapse
|
4
|
Samaro A, Cristancho A, Rivas A, Valtierra R, Beck S, Cantu J, Miranda M, Vacio A, Cardenas Muedano O, Holgado A. The daf-7(e1372) mutation rescues dauer formation defects seen in C. elegans unc-33 mutants. Front Physiol 2023; 14:975878. [PMID: 36814478 PMCID: PMC9939912 DOI: 10.3389/fphys.2023.975878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Accepted: 01/12/2023] [Indexed: 02/09/2023] Open
Abstract
Collapsin response mediator protein-2 (CRMP2) in humans, UNC-33 in C. elegans, is a molecule that mediates axonal outgrowth and stability. UNC-33/CRMP2 has been hypothesized as a potential drug target for treating Alzheimer's and other neurodegenerative diseases, which can often be attributed in part to aging. In aging, CRMP2 becomes hyperphosphorylated, which decreases the protein's functionality, destabilizes the cellular skeleton, and contributes to neurodegeneration. In C. elegans, aging can be slowed by entering dauer diapause; a non-aging developmental stage turned on when the DAF-7/TGFβ signaling pathway is silenced in response to environmental stressors. In our laboratory, we discovered that unc-33 mutants are unable to form dauers in response to environmental stressors, but the mechanism behind this is still unknown. Here, we present a study that investigates whether a mutation in the daf-7 gene which leads to a temperature sensitive constitutive dauer phenotype can rescue phenotypes characteristic of unc-33 mutants. To this end, we created unc-33; daf-7 double mutants and quantified proper dauer formation after exposure to unfavorable environmental conditions. In addition, we tested how the introduction of the daf-7 mutation would affect the locomotion of the double mutants on an agar plate and a liquid medium. Furthermore, we examined axonal elongation of the double mutants using a transgene, juIs76, which expresses GFP in GABAergic motor neurons. Our analysis of unc-33; daf-7 double mutants showed that introducing the daf-7 mutation into an unc-33 mutant rescued dauer formation. However, further studies revealed that the unc-33; daf-7 double mutants had defects in axonal outgrowth of their D-type motor neuron which had been previously seen in unc-33 single mutants and impaired locomotion. Based on these results, we concluded that unc-33 mutants might have a problem suppressing DAF-7 signaling under unfavorable environmental conditions, leading to the activation of reproductive programs and the development of adults instead of dauers.
Collapse
|
5
|
Lopes F, Miranda M, Ye A, Castro A, Pé-Leve P, Pereira E Silva R, Palma Dos Reis J. Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00188-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
6
|
Miranda M, Nieves H, Caceres W, Medina N. !No crystals, no problem! A rare case of Nivolumab induced arthritis. Am J Med Sci 2023. [DOI: 10.1016/s0002-9629(23)00242-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
7
|
Miranda M, Leitão T, Ferreira C, Fernandes M, Castro A, Lopes F, Palma Dos Reis J. Hereditary renal cell carcinoma surveillance protocols - a review and new surveillance protocol proposal. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02555-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
8
|
Miranda M, Sandul A, Fernandes M, Lopes F, Castro A, Oliveira P, Leitão T, Martins F, Palma Reis J. McAninch penile circular skin flap urethroplasty: Do skin flaps still have a role in complex urethral strictures? EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02079-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
9
|
Mateo E, Tonino RPB, Canto A, Monroy Noyola A, Miranda M, Soria JM, Garcia Esparza MA. The Neurotoxic Effect of Ochratoxin-A on the Hippocampal Neurogenic Niche of Adult Mouse Brain. Toxins (Basel) 2022; 14:toxins14090624. [PMID: 36136561 PMCID: PMC9501519 DOI: 10.3390/toxins14090624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Revised: 07/24/2022] [Accepted: 08/31/2022] [Indexed: 11/16/2022] Open
Abstract
Ochratoxin A (OTA) is a common secondary metabolite of Aspergillus ochraceus, A. carbonarius, and Penicillium verrucosum. This mycotoxin is largely present as a contaminant in several cereal crops and human foodstuffs, including grapes, corn, nuts, and figs, among others. Preclinical studies have reported the involvement of OTA in metabolic, physiologic, and immunologic disturbances as well as in carcinogenesis. More recently, it has also been suggested that OTA may impair hippocampal neurogenesis in vivo and that this might be associated with learning and memory deficits. Furthermore, aside from its widely proven toxicity in tissues other than the brain, there is reason to believe that OTA contributes to neurodegenerative disorders. Thus, in this present in vivo study, we investigated this possibility by intraperitoneally (i.p.) administering 3.5 mg OTA/kg body weight to adult male mice to assess whether chronic exposure to this mycotoxin negatively affects cell viability in the dentate gyrus of the hippocampus. Immunohistochemistry assays showed that doses of 3.5 mg/kg caused a significant and dose-dependent reduction in repetitive cell division and branching (from 12% to 62%). Moreover, the number of countable astrocytes (p < 0.001), young neurons (p < 0.001), and mature neurons (p < 0.001) negatively correlated with the number of i.p. OTA injections administered (one, two, three, or six repeated doses). Our results show that OTA induced adverse effects in the hippocampus cells of adult mice brain tissue when administered in cumulative doses.
Collapse
Affiliation(s)
- Eva Mateo
- Department of Microbiology and Ecology, School of Medicine and Dentistry, University of Valencia, 46001 Valencia, Spain
| | | | - Antolin Canto
- Department of Biomedical Sciences, Cardenal Herrera University-CEU Universities, 46001 Valencia, Spain
| | - Antonio Monroy Noyola
- Neuroprotection Laboratory, Faculty of Pharmacy, Autonomous University of the State of Morelos, Cuernavaca, Morelos 98100, Mexico
| | - Maria Miranda
- Department of Biomedical Sciences, Cardenal Herrera University-CEU Universities, 46001 Valencia, Spain
| | - Jose Miguel Soria
- Department of Biomedical Sciences, Cardenal Herrera University-CEU Universities, 46001 Valencia, Spain
- Correspondence: (J.M.S.); (M.A.G.E.)
| | - María Angeles Garcia Esparza
- Department of Pharmacy, Cardenal Herrera University-CEU Universities, 46001 Valencia, Spain
- Correspondence: (J.M.S.); (M.A.G.E.)
| |
Collapse
|
10
|
Morici JF, Cicuttin G, Silva A, Gallo FT, Miranda M, Beluscio M, Zold C, Bekinschtein P, Weisstaub NV. Serotonin Type 2a Receptor in the Prefrontal Cortex Controls Perirhinal Cortex Excitability During Object Recognition Memory Recall. Neuroscience 2022; 497:196-205. [PMID: 35597334 DOI: 10.1016/j.neuroscience.2022.05.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 05/06/2022] [Accepted: 05/12/2022] [Indexed: 10/18/2022]
Abstract
Previous experiences can drive adaptive behavior based on different characteristics, including contextual ones. Indeed, contextual information can be used as a criterion to guide the recall of the most relevant memory trace and the inhibition of others. The medial Prefontal Cortex (mPFC) has been proposed as an area that plays a pivotal role in regulating the retrieval of memory traces in downstream regions. Also, we have shown that mPFC Serotonin 2a Receptors (5-HT2aR) modulates the retrieval of a contextually guided recognition memory task and modulates the retrieval and reconsolidation of memories in the Perirhinal Cortex (PRH). However, how the mPFC output mediated by the 5-HT2aR activity is modulating memory retrieval in the PRH is a question that remains unclear. To tackle this question, we analyzed neuronal activity in the PRH and mPFC, by measuring expression of the immediate early gene c-Fos. We combined behavioral, pharmacological and immunohistochemical techniques to examine how mPFC 5-HT2aR controls mPFC and the PRH activity. We found that blockade of mPFC 5-HT2aR increase the level of c-Fos expression in the PHR and that this increase correlates with animals' performance in the task. We also found an increase in c-Fos expression in the mPFC after mPFC 5-HT2aR blockade that does not correlate with the animals' behavioral response. However, these changes showed a significant correlation with those observed in the PRH. These results suggest that mPFC 5-HT2aR signaling may modulate the behavioral response during memory recall by controlling the neuronal activation in the PRH.
Collapse
Affiliation(s)
- J F Morici
- Instituto de Neurociencias Cognitiva y Traslacional, Concejo Nacional de Investigaciones Científicas y tecnológicas (CONICET), Universidad Favaloro, Instituto de Neurología Cognitiva (INECO), Pacheco de Melo 1860, C1126AAB Buenos Aires, Argentina
| | - G Cicuttin
- Instituto de Neurociencias Cognitiva y Traslacional, Concejo Nacional de Investigaciones Científicas y tecnológicas (CONICET), Universidad Favaloro, Instituto de Neurología Cognitiva (INECO), Pacheco de Melo 1860, C1126AAB Buenos Aires, Argentina
| | - A Silva
- Instituto de Fisiología y Biofísica "Bernardo Houssay" (IFIBIO-Houssay), Grupo de Neurociencia de Sistemas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Buenos Aires, Argentina
| | - F T Gallo
- Instituto de Neurociencias Cognitiva y Traslacional, Concejo Nacional de Investigaciones Científicas y tecnológicas (CONICET), Universidad Favaloro, Instituto de Neurología Cognitiva (INECO), Pacheco de Melo 1860, C1126AAB Buenos Aires, Argentina
| | - M Miranda
- Instituto de Neurociencias Cognitiva y Traslacional, Concejo Nacional de Investigaciones Científicas y tecnológicas (CONICET), Universidad Favaloro, Instituto de Neurología Cognitiva (INECO), Pacheco de Melo 1860, C1126AAB Buenos Aires, Argentina
| | - M Beluscio
- Instituto de Fisiología y Biofísica "Bernardo Houssay" (IFIBIO-Houssay), Grupo de Neurociencia de Sistemas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Buenos Aires, Argentina
| | - C Zold
- Instituto de Fisiología y Biofísica "Bernardo Houssay" (IFIBIO-Houssay), Grupo de Neurociencia de Sistemas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Buenos Aires, Argentina
| | - P Bekinschtein
- Instituto de Neurociencias Cognitiva y Traslacional, Concejo Nacional de Investigaciones Científicas y tecnológicas (CONICET), Universidad Favaloro, Instituto de Neurología Cognitiva (INECO), Pacheco de Melo 1860, C1126AAB Buenos Aires, Argentina
| | - N V Weisstaub
- Instituto de Neurociencias Cognitiva y Traslacional, Concejo Nacional de Investigaciones Científicas y tecnológicas (CONICET), Universidad Favaloro, Instituto de Neurología Cognitiva (INECO), Pacheco de Melo 1860, C1126AAB Buenos Aires, Argentina.
| |
Collapse
|
11
|
Collins J, Varghese D, Miranda M, Nordstrom B, Murphy B, Harland D. 186P A real-world study on prevalence of and outcomes related to brain metastases among patients with HER2-positive metastatic breast cancer (mBC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.03.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
12
|
Miranda M, Bonekamp NA, Kühl I. Starting the engine of the powerhouse: mitochondrial transcription and beyond. Biol Chem 2022; 403:779-805. [PMID: 35355496 DOI: 10.1515/hsz-2021-0416] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2021] [Accepted: 03/09/2022] [Indexed: 12/25/2022]
Abstract
Mitochondria are central hubs for cellular metabolism, coordinating a variety of metabolic reactions crucial for human health. Mitochondria provide most of the cellular energy via their oxidative phosphorylation (OXPHOS) system, which requires the coordinated expression of genes encoded by both the nuclear (nDNA) and mitochondrial genomes (mtDNA). Transcription of mtDNA is not only essential for the biogenesis of the OXPHOS system, but also generates RNA primers necessary to initiate mtDNA replication. Like the prokaryotic system, mitochondria have no membrane-based compartmentalization to separate the different steps of mtDNA maintenance and expression and depend entirely on nDNA-encoded factors imported into the organelle. Our understanding of mitochondrial transcription in mammalian cells has largely progressed, but the mechanisms regulating mtDNA gene expression are still poorly understood despite their profound importance for human disease. Here, we review mechanisms of mitochondrial gene expression with a focus on the recent findings in the field of mammalian mtDNA transcription and disease phenotypes caused by defects in proteins involved in this process.
Collapse
Affiliation(s)
- Maria Miranda
- Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, D-50931, Germany
| | - Nina A Bonekamp
- Department of Neuroanatomy, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, D-68167, Germany
| | - Inge Kühl
- Department of Cell Biology, Institute of Integrative Biology of the Cell (I2BC), UMR9198, CEA, CNRS, Université Paris-Saclay, Gif-sur-Yvette, F-91190, France
| |
Collapse
|
13
|
Miranda M, Avila I, Esparza J, Shwartz Y, Hsu YC, Berdeaux R, Lowry WE. Defining a Role for G-Protein Coupled Receptor/cAMP/CRE-Binding Protein Signaling in Hair Follicle Stem Cell Activation. J Invest Dermatol 2022; 142:53-64.e3. [PMID: 34280464 PMCID: PMC8989631 DOI: 10.1016/j.jid.2021.05.031] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Revised: 04/30/2021] [Accepted: 05/03/2021] [Indexed: 01/03/2023]
Abstract
Manipulation of adrenergic signaling has been shown experimentally and clinically to affect hair follicle growth. In this study, we provide direct evidence that canonical cAMP/CRE-binding protein signaling through adrenergic receptors can regulate hair follicle stem cell (HFSC) activation and hair cycle. We found that CRE-binding protein activation is regulated through the hair cycle and coincides with HFSC activation. Both isoproterenol and procaterol, agonists of adrenergic receptors, show the capacity to activate the hair cycle in mice. Furthermore, deletion of ADRB2 receptor, which is thought to mediate sympathetic nervous system regulation of HFSCs, was sufficient to block HFSC activation. Downstream, stimulation of adenylyl cyclase with forskolin or inhibition of phosphodiesterase to increase cAMP accumulation or direct application of cAMP was each sufficient to promote HFSC activation and accelerate initiation of hair cycle. Genetic induction of a Designer Receptors Exclusively Activated by Designer Drug allele showed that G-protein coupled receptor/GαS stimulation, specifically in HFSCs, promoted the activation of the hair cycle. Finally, we provide evidence that G-protein coupled receptor/CRE-binding protein signaling can potentially act on HFSCs by promoting glycolytic metabolism, which was previously shown to stimulate HFSC activation. Together, these data provide mechanistic insights into the role of sympathetic innervation on HFSC function.
Collapse
Affiliation(s)
- M Miranda
- Molecular Biology Institute, UCLA, Los Angeles, CA 90095
| | - I Avila
- Department of Molecular Cell and Developmental Biology, UCLA, Los Angeles, CA 90095
| | - J Esparza
- Department of Molecular Cell and Developmental Biology, UCLA, Los Angeles, CA 90095
| | - Y Shwartz
- Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Stem Cell Institute, Cambridge, MA 02138
| | - YC Hsu
- Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Stem Cell Institute, Cambridge, MA 02138
| | - R Berdeaux
- Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston
| | - WE Lowry
- Molecular Biology Institute, UCLA, Los Angeles, CA 90095, Department of Molecular Cell and Developmental Biology, UCLA, Los Angeles, CA 90095, Division of Dermatology, DGSOM, UCLA, Los Angeles, CA 90095, Broad Center for Regenerative Medicine, UCLA, Los Angeles, CA 90095, Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095
| |
Collapse
|
14
|
Junior L, Baroudi K, Barroso LS, Miranda M, Vitti R, Brandt W. Bond strength of self-adhesive resin cement to dentin using different adhesion protocols. J Clin Exp Dent 2022; 14:e35-e39. [PMID: 35070122 PMCID: PMC8760965 DOI: 10.4317/jced.59043] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Accepted: 12/13/2021] [Indexed: 11/05/2022] Open
|
15
|
Fernandes M, Miranda M, Castro A, Lopes F, Garcia R, Pereira S, Palma Reis J. Is transurethral resection alone accurate enough for the diagnosis of variant histology bladder cancer compared with radical cystectomy? A 12-year retrospective study. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)03189-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
16
|
Miranda M, Leitão T, Maes K. Robot-assisted radical nephroureterectomy with extravesical excision of the intramural segment of the ureter. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)02306-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
17
|
Walker MA, Miranda M, Allred A, Mootha VK. On the dynamic and even reversible nature of Leigh syndrome: Lessons from human imaging and mouse models. Curr Opin Neurobiol 2021; 72:80-90. [PMID: 34656053 PMCID: PMC8901530 DOI: 10.1016/j.conb.2021.09.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2021] [Revised: 08/01/2021] [Accepted: 09/07/2021] [Indexed: 12/13/2022]
Abstract
Leigh syndrome (LS) is a neurodegenerative disease characterized by bilaterally symmetric brainstem or basal ganglia lesions. More than 80 genes, largely impacting mitochondrial energy metabolism, can underlie LS, and no approved medicines exist. Described 70 years ago, LS was initially diagnosed by the characteristic, necrotic lesions on autopsy. It has been broadly assumed that antemortem neuroimaging abnormalities in these regions correspond to end-stage histopathology. However, clinical observations and animal studies suggest that neuroimaging findings may represent an intermediate state, that is more dynamic than previously appreciated, and even reversible. We review this literature, discuss related conditions that are treatable, and present two new LS cases with radiographic improvement. We review studies in which hypoxia reverses advanced LS in a mouse model. The fluctuating and potentially reversible nature of radiographic LS lesions will be important in clinical trial design. Better understanding of this plasticity could lead to new therapies.
Collapse
Affiliation(s)
- Melissa A Walker
- Howard Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital, United States; Broad Institute of Harvard, MIT, United States; Department of Neurology, Massachusetts General Hospital, United States.
| | - Maria Miranda
- Howard Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital, United States; Broad Institute of Harvard, MIT, United States
| | - Amanda Allred
- Howard Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital, United States
| | - Vamsi K Mootha
- Howard Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital, United States; Broad Institute of Harvard, MIT, United States.
| |
Collapse
|
18
|
Cheema P, Heeg B, Dyer M, Wu YL, John T, Shepherd F, de Marinis F, Melosky B, Samson B, Moldaver D, Shaw S, Miranda M, Verhoek A. 1165P Modelling long-term survival outcomes in patients with stage (stg) IB–IIIA EGFR-mutated NSCLC from the ADAURA trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
19
|
Brito A, Santos T, Herculano K, Miranda M, Sá AK, Carvalho JL, Albertini R, Castro-Faria-Neto H, Ligeiro-de-Oliveira AP, Aimbire F. The MAPKinase Signaling and the Stimulatory Protein-1 (Sp1) Transcription Factor Are Involved in the Phototherapy Effect on Cytokines Secretion from Human Bronchial Epithelial Cells Stimulated with Cigarette Smoke Extract. Inflammation 2021; 44:1643-1661. [PMID: 33730343 DOI: 10.1007/s10753-021-01448-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2018] [Revised: 11/01/2019] [Accepted: 03/07/2021] [Indexed: 10/21/2022]
Abstract
The present study was aimed to investigate the phototherapy effect with low-level laser on human bronchial epithelial cells activated by cigarette smoke extract (CSE). Phototherapy has been reported to actuate positively for controlling the generation/release of anti-inflammatory and pro-inflammatory mediators from different cellular type activated by distinct stimuli. It is not known whether the IL-8 and IL-10 release from CSE-stimulated human bronchial epithelium (BEAS) cells can be influenced by phototherapy. Human bronchial epithelial cell (BEAS) line was cultured in a medium with CSE and irradiated (660 nm) at 9 J. Apoptosis index was standardized with Annexin V and the cellular viability was evaluated by MTT. IL-8, IL-10, cAMP, and NF-κB were measured by ELISA as well as the Sp1, JNK, ERK1/2, and p38MAPK. Phototherapy effect was studied in the presence of mithramycin or the inhibitors of JNK or ERK. The IL-8, cAMP, NF-κB, JNK, p38, and ERK1/2 were downregulated by phototherapy. Both the JNK and the ERK inhibitors potentiated the phototherapy effect on IL-8 as well as on cAMP secretion from BEAS. On the contrary, IL-10 and Sp1 were upregulated by phototherapy. The mithramycin blocked the phototherapy effect on IL-10. The results suggest that phototherapy has a dual effect on BEAS cells because it downregulates the IL-8 secretion by interfering with CSE-mediated signaling pathways, and oppositely upregulates the IL-10 secretion through of Sp1 transcription factor. The manuscript provides evidence that the phototherapy can interfere with MAPK signaling via cAMP in order to attenuate the IL-8 secretion from CSE-stimulated BEAS. In addition, the present study showed that phototherapy effect is driven to downregulation of the both the IL-8 and the ROS secretion and at the same time the upregulation of IL-10 secretion. Besides it, the increase of Sp-1 transcription factor was crucial for laser effect in upregulating the IL-10 secretion. The dexamethasone corticoid produces a significant inhibitory effect on IL-8 as well as ROS secretion, but on the other hand, the corticoid blocked the IL-10 secretion. Taking it into consideration, it is reasonable to suggest that the beneficial effect of laser therapy on lung diseases involves its action on unbalance between pro-inflammatory and anti-inflammatory mediators secreted by human bronchial epithelial cells through different signaling pathway.
Collapse
Affiliation(s)
- A Brito
- Pos-graduation in Biophotonic, University Nove de Julho - Uninove, São Paulo, São Paulo, Brazil
| | - T Santos
- Pos-graduation in Biophotonic, University Nove de Julho - Uninove, São Paulo, São Paulo, Brazil
| | - K Herculano
- Pos-graduation in Biophotonic, University Nove de Julho - Uninove, São Paulo, São Paulo, Brazil
| | - M Miranda
- Pos-graduation in Biophotonic, University Nove de Julho - Uninove, São Paulo, São Paulo, Brazil
| | - A K Sá
- Department of Science and Technology, Institute of Science and Technology, Federal University of São Paulo - UNIFESP, Rua Talim, no. 330 - Vila Nair, CEP: 12231-280, São José dos Campos, São Paulo, Brazil
| | - J L Carvalho
- Department of Science and Technology, Institute of Science and Technology, Federal University of São Paulo - UNIFESP, Rua Talim, no. 330 - Vila Nair, CEP: 12231-280, São José dos Campos, São Paulo, Brazil
| | - R Albertini
- Department of Science and Technology, Institute of Science and Technology, Federal University of São Paulo - UNIFESP, Rua Talim, no. 330 - Vila Nair, CEP: 12231-280, São José dos Campos, São Paulo, Brazil
| | - H Castro-Faria-Neto
- Laboratory of Immunopharmacology, Oswaldo Cruz Foundation - FioCruz, Rio de Janeiro, Rio de Janeiro, Brazil
| | - A P Ligeiro-de-Oliveira
- Pos-graduation in Biophotonic, University Nove de Julho - Uninove, São Paulo, São Paulo, Brazil
| | - Flávio Aimbire
- Department of Science and Technology, Institute of Science and Technology, Federal University of São Paulo - UNIFESP, Rua Talim, no. 330 - Vila Nair, CEP: 12231-280, São José dos Campos, São Paulo, Brazil.
| |
Collapse
|
20
|
Franco R, Barlattani A, Perrone MA, Basili M, Miranda M, Costacurta M, Gualtieri P, Pujia A, Merra G, Bollero P. Obesity, bariatric surgery and periodontal disease: a literature update. Eur Rev Med Pharmacol Sci 2021; 24:5036-5045. [PMID: 32432767 DOI: 10.26355/eurrev_202005_21196] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Obesity is linked to other systemic diseases, such as diabetes mellitus, dyslipidemia, and arterial hypertension. These comorbidities increase the risk of developing cardiovascular disease risk. Adipose tissue is a true endocrine organ and releases various pro-inflammatory cytokines. Periodontal disease (PD) is a chronic inflammatory disorder of the gingiva and bone support (periodontal tissues) that surrounds the teeth. The relationship between obesity and an increased risk of developing PD is already known in the literature. Many studies correlated the cardiometabolic risk with periodontal disease. Bariatric surgery is a way to reduce the adipose tissue in obese patients, that meet specific criteria. It has been observed that this type of surgery usually reduces both the systemic inflammation and the cardiometabolic risk. Some authors have hypothesized that, as a result, the progression of periodontal disease is also reduced. Five articles are analyzed in this systematic review. In these papers, the periodontal health before and after the bariatric surgery was compared. However, the conclusion of the previous studies demonstrated a scarce literature and did not confirm the reduction of periodontal disease after bariatric surgery, but a reduction of cardiometabolic risk. Therefore, periodontal disease in no way influences the reduction of cardiovascular risk after bariatric surgery.
Collapse
Affiliation(s)
- R Franco
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Angeles-Hernandez JC, Miranda M, Muñoz-Benitez AL, Vieyra-Alberto R, Morales-Aguilar N, Paz EA, Gonzalez-Ronquillo M. Zinc supplementation improves growth performance in small ruminants: a systematic review and meta-regression analysis. Anim Prod Sci 2021. [DOI: 10.1071/an20628] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Appropriate supplementation of trace minerals is fundamental to enhance the metabolic status of growing animals and promote an adequate expression of genetic potential. Zinc (Zn) is an essential mineral fundamental in many biological processes that are related to growth, energy balance and immunity. The aim of the present study was to analyse the effect of Zn supplementation on growth parameters in small ruminants by using a meta-analytic approach. Sources of heterogeneity were explored using a meta-regression analysis. The final database was integrated from a total of 53 trials. Only indexed articles that provided an effect size measure, variability measure, sample size and randomisation of the procedure were considered. The dependent variables considered for the study were average daily gain (ADG), dry-matter intake (DMI), feed conversion ratio (FCR), final bodyweight, and glucose blood concentration. The exploratory variables included species (sheep and goat), breed, production level, Zn source and dosage. The ‘meta’ package in R statistical software was used to conduct the meta-analyses. For response variables that showed substantial heterogeneity (I2 > 50%), mixed-effect models (meta-regression analysis) were constructed to explore the sources of heterogeneity using the ‘Metafor’ package. DMI was higher in animals supplemented with Zn (>21.08 g/day, P = 0.0001). Breed, species, production level, and dosage reduced heterogeneity of DMI response from I2 = 84.8 to I2 = 48.1%. Zn-supplemented animals showed higher ADG (17.39 g/day, P = 0.001), which was affected by species, breed dosage and Zn-source. Zn supplementation improved feed efficiency, with lower values of FCR (–1.56 g/g, P < 0.0001). There was a positive relationship between the dosage and effect size in all outcome variables (P < 0.05). Zn-proteinate showed the best response in both species to ADG, FCR and final body weight. Our findings of the systematic review concluded that dietary Zn supplementation improves growth performance in small ruminants and their level of response is influenced mainly by species, production level, and Zn-source and dosage.
Collapse
|
22
|
Castelo B, Miranda M, Vieira A. Weight evolution of patients followed on ambulatory artificial nutrition team. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, Goodman RP, Grabarek Z, Haas ME, Hung WHW, Joshi PR, Jourdain AA, Kim SH, Kotrys AV, Lam SS, McCoy JG, Meisel JD, Miranda M, Panda A, Patgiri A, Rogers R, Sadre S, Shah H, Skinner OS, To TL, Walker M, Wang H, Ward PS, Wengrod J, Yuan CC, Calvo SE, Mootha VK. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 2020; 49:D1541-D1547. [PMID: 33174596 PMCID: PMC7778944 DOI: 10.1093/nar/gkaa1011] [Citation(s) in RCA: 603] [Impact Index Per Article: 150.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Revised: 10/12/2020] [Accepted: 10/14/2020] [Indexed: 02/04/2023] Open
Abstract
The mammalian mitochondrial proteome is under dual genomic control, with 99% of proteins encoded by the nuclear genome and 13 originating from the mitochondrial DNA (mtDNA). We previously developed MitoCarta, a catalogue of over 1000 genes encoding the mammalian mitochondrial proteome. This catalogue was compiled using a Bayesian integration of multiple sequence features and experimental datasets, notably protein mass spectrometry of mitochondria isolated from fourteen murine tissues. Here, we introduce MitoCarta3.0. Beginning with the MitoCarta2.0 inventory, we performed manual review to remove 100 genes and introduce 78 additional genes, arriving at an updated inventory of 1136 human genes. We now include manually curated annotations of sub-mitochondrial localization (matrix, inner membrane, intermembrane space, outer membrane) as well as assignment to 149 hierarchical 'MitoPathways' spanning seven broad functional categories relevant to mitochondria. MitoCarta3.0, including sub-mitochondrial localization and MitoPathway annotations, is freely available at http://www.broadinstitute.org/mitocarta and should serve as a continued community resource for mitochondrial biology and medicine.
Collapse
Affiliation(s)
| | | | | | - Tslil Ast
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Connie Chan
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Timothy J Durham
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Russell P Goodman
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Zenon Grabarek
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Mary E Haas
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Wendy H W Hung
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Pallavi R Joshi
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Alexis A Jourdain
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Sharon H Kim
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Anna V Kotrys
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Stephanie S Lam
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Jason G McCoy
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Joshua D Meisel
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Maria Miranda
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Apekshya Panda
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Anupam Patgiri
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Robert Rogers
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Shayan Sadre
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Hardik Shah
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Owen S Skinner
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Tsz-Leung To
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Melissa A Walker
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Hong Wang
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Patrick S Ward
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Jordan Wengrod
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Chen-Ching Yuan
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,Howard Hughes Medical Institute and Departments of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, MA 02114, USA,Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
| | - Sarah E Calvo
- Correspondence may also be addressed to Sarah E. Calvo.
| | - Vamsi K Mootha
- To whom correspondence should be addressed. Tel: +1 617 643 3059;
| |
Collapse
|
24
|
Papadimitrakopoulou V, Mok T, Han JY, Ahn MJ, Delmonte A, Ramalingam S, Kim S, Shepherd F, Laskin J, He Y, Akamatsu H, Theelen W, Su WC, John T, Sebastian M, Mann H, Miranda M, Laus G, Rukazenkov Y, Wu YL. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. Ann Oncol 2020; 31:1536-1544. [DOI: 10.1016/j.annonc.2020.08.2100] [Citation(s) in RCA: 56] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Revised: 08/13/2020] [Accepted: 08/17/2020] [Indexed: 12/26/2022] Open
|
25
|
Miranda M, Sriaroon P, Leiding J, Walter J. M280 DIAGNOSTIC SAGA FOR A FAMILY WITH HIES. Ann Allergy Asthma Immunol 2020. [DOI: 10.1016/j.anai.2020.08.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
26
|
Salgado-Remacha FJ, Alonso B, Crespo H, Cojocaru C, Trull J, Romero R, López-Ripa M, Guerreiro PT, Silva F, Miranda M, L'Huillier A, Arnold CL, Sola ÍJ. Single-shot d-scan technique for ultrashort laser pulse characterization using transverse second-harmonic generation in random nonlinear crystals. Opt Lett 2020; 45:3925-3928. [PMID: 32667320 DOI: 10.1364/ol.397033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Accepted: 06/12/2020] [Indexed: 06/11/2023]
Abstract
We demonstrate a novel dispersion-scan (d-scan) scheme for single-shot temporal characterization of ultrashort laser pulses. The novelty of this method relies on the use of a highly dispersive crystal featuring antiparallel nonlinear domains with a random distribution and size. This crystal, capable of generating a transverse second-harmonic signal, acts simultaneously as the dispersive element and the nonlinear medium of the d-scan device. The resulting in-line architecture makes the technique very simple and robust, allowing the acquisition of single-shot d-scan traces in real time. The retrieved pulses are in very good agreement with independent frequency-resolved optical grating measurements. We also apply the new single-shot d-scan to a terawatt-class laser equipped with a programmable pulse shaper, obtaining an excellent agreement between the applied and the d-scan retrieved dispersions.
Collapse
|
27
|
Avila I, Miranda M, Esparza J, Lowry W. 160 Defining a role for CREB in hair follicle stem cell metabolism. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
28
|
Miranda M, Avila I, Esparza J, Lowry W. 756 Untangling G-protein-coupled receptor signaling and Creb in hair follicle homeostasis. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Sahaboglu A, Miranda M, Canjuga D, Avci-Adali M, Savytska N, Secer E, Feria-Pliego JA, Kayık G, Durdagi S. Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration. Cell Mol Life Sci 2020; 77:2199-2216. [PMID: 31451894 PMCID: PMC11104953 DOI: 10.1007/s00018-019-03283-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2019] [Revised: 07/26/2019] [Accepted: 08/15/2019] [Indexed: 12/18/2022]
Abstract
The enzyme poly-ADP-ribose-polymerase (PARP) has important roles for many forms of DNA repair and it also participates in transcription, chromatin remodeling and cell death signaling. Currently, some PARP inhibitors are approved for cancer therapy, by means of canceling DNA repair processes and cell division. Drug repurposing is a new and attractive aspect of therapy development that could offer low-cost and accelerated establishment of new treatment options. Excessive PARP activity is also involved in neurodegenerative diseases including the currently untreatable and blinding retinitis pigmentosa group of inherited retinal photoreceptor degenerations. Hence, repurposing of known PARP inhibitors for patients with non-oncological diseases might provide a facilitated route for a novel retinitis pigmentosa therapy. Here, we demonstrate and compare the efficacy of two different PARP inhibitors, BMN-673 and 3-aminobenzamide, by using a well-established retinitis pigmentosa model, the rd1 mouse. Moreover, the mechanistic aspects of the PARP inhibitor-induced protection were also investigated in the present study. Our results showed that rd1 rod photoreceptor cell death was decreased by about 25-40% together with the application of these two PARP inhibitors. The wealth of human clinical data available for BMN-673 highlights a strong potential for a rapid clinical translation into novel retinitis pigmentosa treatments. Remarkably, we have found that the efficacy of 3 aminobenzamide was able to decrease PARylation at the nanomolar level. Our data also provide a link between PARP activity with the Wnt/β-catenin pathway and the major intracellular antioxidant concentrations behind the PARP-dependent retinal degeneration. In addition, molecular modeling studies were integrated with experimental studies for better understanding of the role of PARP1 inhibitors in retinal degeneration.
Collapse
Affiliation(s)
- Ayse Sahaboglu
- Division of Experimental Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany.
| | - Maria Miranda
- Departamento Ciencias Biomédicas, Universidad Cardenal Herrera-CEU Universities, Valencia, Spain
| | - Denis Canjuga
- Department of Thoracic and Cardiovascular Surgery, University Hospital Tübingen, Tübingen, Germany
| | - Meltem Avci-Adali
- Department of Thoracic and Cardiovascular Surgery, University Hospital Tübingen, Tübingen, Germany
| | - Natalia Savytska
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
| | - Enver Secer
- Department of Medical Genetics, Erciyes University, Kayseri, Turkey
| | | | - Gülru Kayık
- Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahcesehir University, Istanbul, Turkey
| | - Serdar Durdagi
- Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahcesehir University, Istanbul, Turkey.
| |
Collapse
|
30
|
Carvalho JL, Miranda M, Fialho AK, Castro-Faria-Neto H, Anatriello E, Keller AC, Aimbire F. Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl/6 mice: Relevance to inflammatory markers in human bronchial epithelial cells. PLoS One 2020; 15:e0225560. [PMID: 32330145 PMCID: PMC7182195 DOI: 10.1371/journal.pone.0225560] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Accepted: 04/03/2020] [Indexed: 01/10/2023] Open
Abstract
COPD is a prevalent lung disease with significant impacts on public health. Affected airways exhibit pulmonary neutrophilia and consequent secretion of pro-inflammatory cytokines and proteases, which result in lung emphysema. Probiotics act as nonspecific modulators of the innate immune system that improve several inflammatory responses. To investigate the effect of Lactobacillus rhamnosus (Lr) on cigarette smoke (CS)-induced COPD C57Bl/6 mice were treated with Lr during the week before COPD induction and three times/week until euthanasia. For in vitro assays, murine bronchial epithelial cells as well as human bronchial epithelial cells exposed to cigarette smoke extract during 24 hours were treated with Lr 1 hour before CSE addition. Lr treatment attenuated the inflammatory response both in the airways and lung parenchyma, reducing inflammatory cells infiltration and the production of pro-inflammatory cytokines and chemokines. Also, Lr-treated mice presented with lower metalloproteases in lung tissue and lung remodeling. In parallel to the reduction in the expression of TLR2, TLR4, TLR9, STAT3, and NF-κB in lung tissue, Lr increased the levels of IL-10 as well as SOCS3 and TIMP1/2, indicating the induction of an anti-inflammatory environment. Similarly, murine bronchial epithelial cells as well as human bronchial epithelial cells (BEAS) exposed to CSE produced pro-inflammatory cytokines and chemokines, which were inhibited by Lr treatment in association with the production of anti-inflammatory molecules. Moreover, the presence of Lr also modulated the expression of COPD-associated transcription found into BALF of COPD mice group, i.e., Lr downregulated expression of NF-κB and STAT3, and inversely upregulated increased expression of SOCS3. Thus, our findings indicate that Lr modulates the balance between pro- and anti-inflammatory cytokines in human bronchial epithelial cells upon CS exposure and it can be a useful tool to improve the lung inflammatory response associated with COPD.
Collapse
Affiliation(s)
- J. L. Carvalho
- Department of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil
| | - M. Miranda
- Department of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil
| | - A. K. Fialho
- Department of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil
| | | | - E. Anatriello
- Department of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil
| | - A. C. Keller
- Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, São Paulo, Brazil
| | - F. Aimbire
- Department of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil
| |
Collapse
|
31
|
Carneiro-Leão L, Carolino F, Pineda F, Miranda M, Plácido JL. A Possible New Mushroom Allergen in a Case of Occupational Asthma. J Investig Allergol Clin Immunol 2020; 29:243-244. [PMID: 31219039 DOI: 10.18176/jiaci.0367] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- L Carneiro-Leão
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| | - F Carolino
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| | - F Pineda
- Diater Laboratories, Madrid, Spain
| | - M Miranda
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| | - J L Plácido
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| |
Collapse
|
32
|
López-Malo D, Villarón-Casares CA, Alarcón-Jiménez J, Miranda M, Díaz-Llopis M, Romero FJ, Villar VM. Curcumin as a Therapeutic Option in Retinal Diseases. Antioxidants (Basel) 2020; 9:antiox9010048. [PMID: 31935797 PMCID: PMC7023263 DOI: 10.3390/antiox9010048] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Revised: 12/27/2019] [Accepted: 12/29/2019] [Indexed: 12/18/2022] Open
Abstract
The retina is subjected to oxidative stress due to its high vascularization, long time light exposition and a high density of mitochondria. Oxidative stress can lead to pathological processes, like cell apoptosis, angiogenesis and inflammation ending in retinal pathologies. Curcumin, a major bioactive component obtained from the spice turmeric (Curcuma longa) rhizome has been used for centuries in Asian countries for cooking and for curing all kinds of diseases like dysentery, chest congestion and pain in general, due to its antioxidant effects. Curcumin prevents the formation of reactive oxygen species and so it is a good protective agent. Curcumin has shown also anti-inflammatory, and antitumor properties. Curcumin is a natural product, which can be a therapeutic option in a variety of retinal diseases due to its pleiotropic properties. Some drawbacks are its poor solubility, bioavailability and lack of stability at physiological conditions; which have been shown in curcumin skeptical publications. In this review, we provide some lights and shadows on curcumin administration on the major retinal pathologies.
Collapse
Affiliation(s)
- Daniel López-Malo
- Facultad de Ciencias de la Salud, Universidad Europea de Valencia, 46010 Valencia, Spain; (D.L.-M.); (C.A.V.-C.)
| | | | - Jorge Alarcón-Jiménez
- Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia, 46001 Valencia, Spain;
| | - Maria Miranda
- Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, 46315 Moncada, Spain; (M.M.); (V.M.V.)
| | - Manuel Díaz-Llopis
- Facultad de Medicina y Odontología, Universitat de Valencia, 46010 Valencia, Spain;
| | - Francisco J. Romero
- Facultad de Ciencias de la Salud, Universidad Europea de Valencia, 46010 Valencia, Spain; (D.L.-M.); (C.A.V.-C.)
- Hospital General de Requena, Conselleria de Sanitat, Generalitat Valenciana, 46340 Valencia, Spain
- Correspondence: ; Tel.: +34-961-0438-83
| | - Vincent M. Villar
- Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, 46315 Moncada, Spain; (M.M.); (V.M.V.)
| |
Collapse
|
33
|
Hillstrom HJ, Soeters R, Miranda M, Backus SI, Hafer J, Gibbons M, Thaqi I, Lenhoff M, Hannan MT, Endo Y, Sculco T, Lane J. Effect of increased serum 25(OH)D and calcium on structure and function of post-menopausal women: a pilot study. Arch Osteoporos 2020; 15:154. [PMID: 33009959 PMCID: PMC7532965 DOI: 10.1007/s11657-020-00814-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Accepted: 09/01/2020] [Indexed: 02/03/2023]
Abstract
UNLABELLED The purpose was to determine if increasing serum 25(OH)D and calcium in postmenopausal women increased skeletal muscle size, strength, balance, and functional task performance while decreasing muscle fatigue. PCSA of the vastus lateralis increased and ascent of stairs time decreased after 6 months of increased serum 25(OH)D. PURPOSE The Institute of Medicine recommends ≥ 20 ng/ml of serum 25-hydroxyvitamin D [25(OH)D] for bone and overall health. Serum 25(OH)D levels have been associated with physical performance, postural sway, and falls. The purpose of this study was to determine if increasing postmenopausal women's serum 25(OH)D levels from 20-30 ng/ml to 40-50 ng/ml improved skeletal muscle size, strength, balance, and functional performance while decreasing skeletal muscle fatigue. METHODS Twenty-six post-menopausal women (60-85 years old) with baseline serum 25(OH)D levels between 20 and 30 ng/ml were recruited. Oral over-the-counter (OTC) vitamin D3 and calcium citrate were prescribed to increase subjects' serum 25(OH)D to levels between 40 and 50 ng/ml, serum calcium levels above 9.2 mg/dl, and PTH levels below 60 pg/ml, which were confirmed at 6 and 12 weeks. Outcome measures assessed at baseline and 6 months included muscle physiological cross-sectional area (PCSA), muscle strength, postural balance, time to perform functional tasks, and muscle fatigue. Repeated measures comparisons between baseline and follow-up were performed. RESULTS Nineteen subjects completed the study. One individual could not afford the time commitment for the repeated measures. Three individuals did not take their vitamin D as recommended. Two subjects were lost to follow-up (lack of interest), and one did not achieve targeted serum 25(OH)D. Vastus lateralis PCSA increased (p = 0.007) and ascent of stair time decreased (p = 0.042) after 6 months of increasing serum 25(OH)D levels from 20-30 ng/ml to 40-50 ng/ml. Isometric strength was unchanged. Anterior-posterior center of pressure (COP) excursion and COP path length decreased (p < 0.1) albeit non-significantly, suggesting balance may improve from increased serum 25(OH)D and calcium citrate levels. CONCLUSIONS Several measures of muscle structure and function were sensitive to elevated serum 25(OH)D and calcium levels indicating that further investigation of this phenomenon in post-menopausal women is warranted.
Collapse
Affiliation(s)
- H. J. Hillstrom
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - R. Soeters
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - M. Miranda
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - S. I. Backus
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - J. Hafer
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA ,Biomechanics Lab, Department of Kinesiology, University of Massachusetts, Totman rm.110, 30 Eastman Lane, Amherst, MA USA
| | - M. Gibbons
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - I. Thaqi
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - M. Lenhoff
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - M. T. Hannan
- Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, 1200 Centre Street, Boston, MA USA
| | - Y. Endo
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - T. Sculco
- Leon Root Motion Analysis Laboratory (LRMALab), Hospital for Special Surgery (HSS), 535 East 70th Street, New York, NY USA
| | - J. Lane
- Metabolic Bone Disease Service, HSS, 535 East 70th Street, New York, NY USA
| |
Collapse
|
34
|
Wu YL, Mok T, Han JY, Ahn MJ, Delmonte A, Ramalingam S, Kim SW, Shepherd F, Laskin J, He Y, Akamatsu H, Theelen W, Su WC, John T, Sebastian M, Mann H, Miranda M, Laus G, Rukazenkov Y, Papadimitrakopoulou V. Overall survival (OS) from the AURA3 phase III study: Osimertinib vs platinum-pemetrexed (plt-pem) in patients (pts) with EGFR T790M advanced non-small cell lung cancer (NSCLC) and progression on a prior EGFR-tyrosine kinase inhibitor (TKI). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz437.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
35
|
Miranda M, Kaur S, Slugh M, Bermudez-Andrews C, Millan C, Fernandez-McInerney K, Kanner AM, Ruiz NV, Ribot R, Lowe M, Palomeque M, Detyniecki K, Rey G. Cross-cultural Convergent Validation of the Spanish and English Versions of the Personal Impact of Epilepsy Scale (PIES) in a Cohort of Patients from a Level IV Epilepsy Center in South Florida. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Objective
To provide further convergent validity on the Personal Impact of Epilepsy Scale (PIES) Spanish version for use in Hispanics with epilepsy.
Participants and Method
This study included 90 patients (22 Hispanic and Spanish speaking - HSS, 30 Hispanic and English speaking – HES, and 38 non-Hispanic and English speaking – NHES) who were diagnosed with epilepsy and referred by their epileptologist for a comprehensive neuropsychological evaluation that, in addition to cognitive measures, also included the Beck Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI), and PIES in English or Spanish- depending on the participant’s primary language. The PIES was created with subscales to measure the effect of seizures, adverse effects of treatment, and comorbidities such as mood disorders on quality of life. We compared scores on the PIES subscales in English and Spanish to determine equivalence. We further examined if language of administration moderated the relationship between PIES subscale scores and depression/anxiety through nonparametric bootstrapping.
Results
There were no significant demographic or clinical differences between the 3 groups examined. ANOVA contrast of mean scores on all PIES subscales between HSS, HES and NHES groups did not reach significance (Seizures F [2,88] = .06 , p = -.93; Medication use F[2,88] = 1.95, p = .14, Comorbidity F[2,88] = .64, p = .52, and total PIES F[2,88] = .19, p = .83). The relationships between PIES and BDI-II/BAI scores were not significantly moderated by language of administration.
Conclusions
Our data suggest clinical equivalency between the English and Spanish versions of the PIES. Furthermore, the relationships between PIES subscales and the BDI-II/BAI were not significantly changed by language of administration. These findings indicate that the Spanish PIES appears to have good convergent validity with the original English version and can be useful in the assessment of quality of life in HSS patients.
Collapse
|
36
|
Miranda M, Kaur S, Slugh M, Bermudez-Andrews C, Millan C, Fernandez – McInerney K, Kanner AM, Velez Ruiz N, Ribot R, Lowe M, Palomeque M, Detyniecki K, Rey G. Intellectual, Psychological, and Clinical Predictors of Quality of Life in Patients with Epilepsy from a Level IV Epilepsy Center in South Florida. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Objective
To examine clinical, cognitive, and psychological predictors of Quality of Life (QOL) among Hispanics and non-Hispanics with epilepsy.
Participants and Method
Data was collected from 90 patients (52 Hispanic; H, 38 Non-Hispanic; NH) diagnosed with epilepsy and referred for neuropsychological evaluation that included measures of depression (BDI-II), anxiety (BAI), and QOL using the Personal Impact of Epilepsy Scale (PIES). We conducted multiple linear regression models with patient’s full-scale IQ, age of seizure onset, duration of seizure disorder, and anxiety and depression symptom severity entered as predictors, with the PIES as outcome measure.
Results
There were no significant differences between H and NH on any demographic or clinical variable except for longer duration of seizure disorder (t = 2.20, p = 0.03) in H. For the complete sample, higher FSIQ predicted better QOL in relation to the perceived disabling effects of seizures (β = .28, p =.02), higher BDI-II scores predicted more negative medication side effects and greater mood related disruption in QOL (β = -2.27, p =.03; β = -3.82, p =.00), and higher BAI scores were the best predictor for worse overall QOL (β = -.29, p = .05). When the sample was divided according to ethnic background, longer seizure duration was associated with the adverse effects of less medication in the H group (β = .32, p =.04), with all other findings being identical to those of the complete sample. When results for NH patients were analyzed, none of the intellectual, psychological and clinical variables were significantly associated with any of the QOL scales; however, the relationship between the BAI and comorbid mood dysfunction approached significance (β = -1.45, p = .059).
Conclusions
Our data indicates that overall QOL was primarily predicted by the severity of anxiety symptoms, but not influenced by overall intelligence, symptoms of depression, and clinical seizure variables.
Collapse
|
37
|
Miranda M, Avila I, Esparza J, Lowry W. LB1133 Untangling the role of G-protein-coupled receptor signaling and CREB in hair follicle homeostasis. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.06.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Lopez IH, Gomez J, Torres L, Acosta J, Arquez M, LaFuerza A, Martinez F, Miranda M, Arenas M. Influence of Statins on Survival Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Inhibitors. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1908] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Resende PC, Caetano B, Matos A, Lopes J, Garcia C, Miranda M, Born P, Motta FC, Brown D, Siqueira M. A31 Diversity change of influenza A (H3N2) strains circulating in Brazil during 2017–8: What to expect in the coming winter? Virus Evol 2019. [PMCID: PMC6735707 DOI: 10.1093/ve/vez002.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The H3N2 subtype of influenza A (H3N2) was the predominant strain during the early months of the 2017 influenza epidemic in Brazil. In Australia, it was responsible for a strong and prolonged 2017 season and reached the Northern hemisphere causing an intense 2017/8 influenza season. Several genetic and antigenic A(H3N2) variants were circulating, which made the decision about which strain to incorporate into the influenza vaccine challenging. For 2018, the WHO selected a new H3N2 strain, A/Singapore/INFIMH-16-0019/2016-like, to replace the strain A/HongKong/4801/2014-like in the Southern Hemisphere trivalent vaccine. The aim of this study was to describe the genetic diversity of influenza A (H3N2) viruses circulating in Brazil between January 2017 and January 2018, checking the match between the vaccines and worldwide circulating strains with the Brazilian influenza strains. Hemagglutinin gene sequencing of the influenza A (H3N2) was performed, followed by a phylogenetic reconstruction using additional database sequences to define genetic groups and compare with other worldwide circulating strains. We observed a large diversity of H3N2 genetic clusters, including 3C.2a, 3C.2a1, 3C.3a, and their subgroups. During the 2016–7, inter-epidemic and 2017 epidemic period the cluster most frequently detected belonged to clade 3C.2a1 (148/185; 80.0%), a distinct group related to the 2017 vaccine strain A/HongKong/4801/2014-like (3C.2a). However, the genetic profile changed during the study period and in the inter-epidemic season 2017–8 the most commonly detected genetic group was the 3C.2a cluster (43/58; 74.1%). Inside this cluster, the majority (34/43; 79.1%) of strains belonged to a single genetic 3C.2a subgroup 2 (3C.2a2), bearing antigenic substitutions T131K and R142K (site A) and R261Q (site E). The dominance of this 3C.2a2 in the 2017–8 inter-epidemic period in Brazil was similar to the 2017–8 season in Europe and Canada according their surveillance data. The new vaccine strain has five to six antigenic changes in comparison to the predominant 3C.2a2 circulating in South America since September 2017 until now. It is possible that the vaccine mismatch will not protect the population against a majority of circulating strains. Surveillance of the vaccine effectiveness supported by antigenic and serological analysis are necessary to prove this hypothesis. However, this highlights the difficulty of vaccine strain selection and highlights the need for of a universal influenza vaccine.
Collapse
Affiliation(s)
- P C Resende
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - B Caetano
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - A Matos
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - J Lopes
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - C Garcia
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - M Miranda
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - P Born
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - F C Motta
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - D Brown
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| | - M Siqueira
- Laboratory of Respiratory Viruses and Measles, National Influenza Centre, MoH and WHO – Oswaldo Cruz Institute – FIOCRUZ, Rio de Janeiro, Brazil
| |
Collapse
|
40
|
Anatriello E, Cunha M, Nogueira J, Carvalho JL, Sá AK, Miranda M, Castro-Faria-Neto H, Keller AC, Aimbire F. Oral feeding of Lactobacillus bulgaricus N45.10 inhibits the lung inflammation and airway remodeling in murine allergic asthma: Relevance to the Th1/Th2 cytokines and STAT6/T-bet. Cell Immunol 2019; 341:103928. [PMID: 31178059 DOI: 10.1016/j.cellimm.2019.103928] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 05/14/2019] [Accepted: 05/22/2019] [Indexed: 12/31/2022]
Abstract
Asthma is a chronic disease with impacts on public health. It affects the airways causing pulmonary inflammation mediated by CD4 T cells type Th2, eosinophilia, mucus hypersecretion, and elevated IgE. The unbalance between cytokines and transcription factors is an important feature in asthma. Probiotics has gaining highlight as a therapy for chronic diseases. Thus, we investigate the Lactobacillus bulgaricus (Lb) effect in murine allergic asthma. BALB/c-mice were sensitized to ovalbumin (OA) on days 0 and 7 and were challenged from day 14-28 with OA. Mice received Lb seven days prior to sensitization and it was kept until day 28. The Lb attenuated the eosinophils infiltration, mucus and collagen secretion, IgE production, pro-inflammatory cytokines, TLR4 expression, GATA3, STAT6 and RORγt in lung. Otherwise, Lb increased the anti-inflammatory cytokines, the T-bet and foxp3. Finally, Lb attenuated the allergic asthma-induced inflammation and airway remodeling by interfering on Th1/Th2 cytokines and STAT6/T-bet transcription factors.
Collapse
Affiliation(s)
- E Anatriello
- Department of Science and Technology, Federal University of São Paulo, PO Box 12231-280, São José dos Campos, SP, Brazil
| | - M Cunha
- Laboratory of Immunopharmacology, FioCruz, Rio de Janeiro, Brazil
| | - J Nogueira
- Laboratory of Experimental Immunopathology, Federal University of São Paulo, São Paulo, SP, Brazil
| | - J L Carvalho
- Department of Science and Technology, Federal University of São Paulo, PO Box 12231-280, São José dos Campos, SP, Brazil
| | - A K Sá
- Department of Science and Technology, Federal University of São Paulo, PO Box 12231-280, São José dos Campos, SP, Brazil
| | - M Miranda
- Department of Science and Technology, Federal University of São Paulo, PO Box 12231-280, São José dos Campos, SP, Brazil
| | | | - A C Keller
- Laboratory of Experimental Immunopathology, Federal University of São Paulo, São Paulo, SP, Brazil
| | - F Aimbire
- Department of Science and Technology, Federal University of São Paulo, PO Box 12231-280, São José dos Campos, SP, Brazil.
| |
Collapse
|
41
|
Jiang S, Koolmeister C, Misic J, Siira S, Kühl I, Silva Ramos E, Miranda M, Jiang M, Posse V, Lytovchenko O, Atanassov I, Schober FA, Wibom R, Hultenby K, Milenkovic D, Gustafsson CM, Filipovska A, Larsson NG. TEFM regulates both transcription elongation and RNA processing in mitochondria. EMBO Rep 2019; 20:embr.201948101. [PMID: 31036713 PMCID: PMC6549021 DOI: 10.15252/embr.201948101] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 03/29/2019] [Accepted: 04/02/2019] [Indexed: 12/22/2022] Open
Abstract
Regulation of replication and expression of mitochondrial DNA (mtDNA) is essential for cellular energy conversion via oxidative phosphorylation. The mitochondrial transcription elongation factor (TEFM) has been proposed to regulate the switch between transcription termination for replication primer formation and processive, near genome‐length transcription for mtDNA gene expression. Here, we report that Tefm is essential for mouse embryogenesis and that levels of promoter‐distal mitochondrial transcripts are drastically reduced in conditional Tefm‐knockout hearts. In contrast, the promoter‐proximal transcripts are much increased in Tefm knockout mice, but they mostly terminate before the region where the switch from transcription to replication occurs, and consequently, de novo mtDNA replication is profoundly reduced. Unexpectedly, deep sequencing of RNA from Tefm knockouts revealed accumulation of unprocessed transcripts in addition to defective transcription elongation. Furthermore, a proximity‐labeling (BioID) assay showed that TEFM interacts with multiple RNA processing factors. Our data demonstrate that TEFM acts as a general transcription elongation factor, necessary for both gene transcription and replication primer formation, and loss of TEFM affects RNA processing in mammalian mitochondria.
Collapse
Affiliation(s)
- Shan Jiang
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.,Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden
| | - Camilla Koolmeister
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.,Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden
| | - Jelena Misic
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.,Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden
| | - Stefan Siira
- Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Perth, WA, Australia
| | - Inge Kühl
- Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany.,Institute of Integrative Biology of the Cell, UMR9198, CEA, CNRS, University Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France
| | - Eduardo Silva Ramos
- Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Maria Miranda
- Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Min Jiang
- Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Viktor Posse
- Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden
| | - Oleksandr Lytovchenko
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.,Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden
| | - Ilian Atanassov
- Proteomics Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Florian A Schober
- Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden.,Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
| | - Rolf Wibom
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.,Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden
| | - Kjell Hultenby
- Division of Clinical Research Centre, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Dusanka Milenkovic
- Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Claes M Gustafsson
- Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden
| | - Aleksandra Filipovska
- Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Perth, WA, Australia
| | - Nils-Göran Larsson
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden .,Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden.,Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany.,Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
42
|
Gálvez F, López-Alonso M, Herrero-Latorre C, Miranda M, Franco D, Lorenzo J. Chemometric characterization of the trace element profile of raw meat from Rubia Gallega x Holstein Friesian calves from an intensive system. Meat Sci 2019; 149:63-69. [DOI: 10.1016/j.meatsci.2018.11.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Revised: 09/28/2018] [Accepted: 11/13/2018] [Indexed: 11/30/2022]
|
43
|
Affiliation(s)
- L Carneiro-Leão
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| | - L Amaral
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| | - D Silva
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| | | | - M Miranda
- Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal
| |
Collapse
|
44
|
Freitas H, Park K, Kim DW, Tiseo M, Hochmair M, Chang GC, Shi YK, Moran T, Chen Y, Laskin J, Solomon B, Miranda M, Rigas J, Cheema P, Kim SW. ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Provencio M, Cheema P, Vansteenkiste J, Cho B, Zhou C, Yu J, Martin C, Park K, He Y, Hu Y, Vicente D, Miranda M, Rigas J, de Marinis F. ASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy446.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Bracco L, Wolman F, Miranda M, Cascone O. Immobilization and purification of soybean seed hull proteins of biotechnological interest identified by shotgun proteomic analysis. N Biotechnol 2018. [DOI: 10.1016/j.nbt.2018.05.1132] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Piotrowska Z, Chmielecki J, Cripps D, Miranda M. P1.01-80 ELIOS: A Multicenter, Open-Label, Molecular Profiling Study of Patients with EGFRm and NSCLC Treated with Osimertinib. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
48
|
Gregg J, Baik C, Dietrich M, Dubinett S, Gerber D, Husain H, Shiller M, Miranda M, Chehab N, West H. P3.01-32 An Open-Label, Non-Randomized, Biomarker Study of Concordance in Non-Invasive and Tissue Tests for T790M Detection in NSCLC. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
49
|
Tiseo M, Santo A, Hochmair M, Geldart T, Metro G, Hanrahan E, Lamberg K, Moran T, Nyhus C, Paredes A, Vansteenkiste J, Vicente D, Miranda M, Rigas J, de Marinis F. ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M-positive non-small cell lung cancer (NSCLC) - European subset. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
Polido G, Miranda M, Junior NC, Caromano F, Reed U, Zanoteli E, Voos M. SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|